Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials.
Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials.
复制标题
DOI:
10.1371/journal.pone.0289478
复制
发表时间:
2023
期刊:
影响因子:
3.7
通讯作者:
中科院分区:
文献类型:
--
作者:
Episodic Future Thinking (EFT) reduces delay discounting and may have the potential as a clinical tool to increase the likelihood of health-promoting behaviors. However, evaluations of EFT in clinical settings require control conditions that match the effort and frequency of cue generation, as well as participants’ expectations of improvement. The Health Information Thinking (HIT) control addresses these issues, but how this control affects delay discounting in individuals with diabetes and obesity when utilizing diabetes-management specific health-information vignettes is unknown. Moreover, little research has explored whether EFT reduces delay discounting in individuals with type 2 diabetes. To this end, we examined the impact of EFT, HIT, and a secondary no-cue control condition (NCC; assessments as usual) on delay discounting in 434 adults with self-reported type 2 diabetes and obesity recruited using Amazon Mechanical Turk. After completing an initial screening questionnaire, eligible participants reported demographics, then were randomized to EFT, HIT, or NCC conditions. Following the generation of seven EFT or HIT cues, participants assigned to EFT or HIT conditions completed a delay discounting task while imagining EFT or HIT cues; no-cue participants completed the task without cues. EFT participants demonstrated significantly lower delay discounting levels than HIT or NCC participants; no differences in delay discounting between HIT and NCC participants were observed. These results suggest that engaging in EFT, but not diabetes-specific HIT, results in lower delay discounting in adults with type 2 diabetes and obesity. This provides further evidence for the appropriateness of the HIT control for clinical trials examining the effect of EFT on delay discounting in adults with self-reported type 2 diabetes.
登录
查看更多内容
影响因子:
4.2
作者:
Hollis-Hansen, Kelseanna;Seidman, Jennifer;Epstein, Leonard H.
通讯作者:
Epstein, Leonard H.
影响因子:
3.9
作者:
Kennedy, Ryan;Clifford, Scott;Winter, Nicholas J. G.
通讯作者:
Winter, Nicholas J. G.
DOI:
10.1177/2167702617696511
发表时间:
2017-07
期刊:
Clinical psychological science : a journal of the Association for Psychological Science
影响因子:
--
作者:
Sze YY;Stein JS;Bickel WK;Paluch RA;Epstein LH
通讯作者:
Epstein LH
影响因子:
3.1
作者:
Epstein LH;Paluch RA;Biondolillo MJ;Stein JS;Quattrin T;Mastrandrea LD;Gatchalian K;Greenawald MH;Bickel WK
通讯作者:
Bickel WK
DOI:
10.1016/s0140-6736(12)60283-9
发表时间:
2012-06-16
期刊:
Lancet (London, England)
影响因子:
--
作者:
Tabák AG;Herder C;Rathmann W;Brunner EJ;Kivimäki M
通讯作者:
Kivimäki M